[go: up one dir, main page]

ATE301195T1 - Acpl dna und polypeptide - Google Patents

Acpl dna und polypeptide

Info

Publication number
ATE301195T1
ATE301195T1 AT99903320T AT99903320T ATE301195T1 AT E301195 T1 ATE301195 T1 AT E301195T1 AT 99903320 T AT99903320 T AT 99903320T AT 99903320 T AT99903320 T AT 99903320T AT E301195 T1 ATE301195 T1 AT E301195T1
Authority
AT
Austria
Prior art keywords
polypeptides
acpl
acpl dna
dna
purified
Prior art date
Application number
AT99903320T
Other languages
English (en)
Inventor
John E Sims
Teresa L Born
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE301195T1 publication Critical patent/ATE301195T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/41Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/417Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99903320T 1998-01-23 1999-01-22 Acpl dna und polypeptide ATE301195T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7230198P 1998-01-23 1998-01-23
US7883598P 1998-03-20 1998-03-20
PCT/US1999/001420 WO1999037773A1 (en) 1998-01-23 1999-01-22 Acpl dna and polypeptides

Publications (1)

Publication Number Publication Date
ATE301195T1 true ATE301195T1 (de) 2005-08-15

Family

ID=26753223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99903320T ATE301195T1 (de) 1998-01-23 1999-01-22 Acpl dna und polypeptide

Country Status (11)

Country Link
US (7) US6664077B1 (de)
EP (1) EP1049777B1 (de)
JP (1) JP4409763B2 (de)
AT (1) ATE301195T1 (de)
AU (1) AU750767B2 (de)
CA (1) CA2318030C (de)
DE (1) DE69926480T2 (de)
ES (1) ES2245085T3 (de)
IL (3) IL137037A0 (de)
NZ (1) NZ505499A (de)
WO (1) WO1999037773A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US20020155526A1 (en) 1998-09-30 2002-10-24 Busfield Samantha J. Novel secreted immunomodulatory proteins and uses thereof
KR20110032012A (ko) 2000-02-10 2011-03-29 아보트 러보러터리즈 사람 인터류킨-18에 결합하는 항체 및 이를 제조하고 사용하는 방법
EP2087908B1 (de) 2001-06-26 2018-05-30 Amgen Inc. Antikörper gegen opgl
NZ566539A (en) 2002-09-06 2010-01-29 Medarex Inc Therapeutic human anti-IL-1R1 monoclonal antibody
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
TW200736277A (en) 2005-11-14 2007-10-01 Amgen Inc RANKL antibody-PTH/PTHrP chimeric molecules
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
CA2801210C (en) * 2010-06-19 2020-07-21 Memorial Sloan-Kettering Cancer Center Anti-gd2 antibodies
CA2824387C (en) 2011-02-09 2019-09-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
CN103649932B (zh) * 2011-05-20 2017-09-26 英特尔公司 资源的分散分配以及用于支持由多个引擎执行指令序列的互连结构
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9708375B2 (en) 2013-03-15 2017-07-18 Amgen Inc. Inhibitory polypeptides specific to WNT inhibitors
RU2680267C2 (ru) 2013-03-15 2019-02-19 Мемориал Слоан Кеттеринг Кэнсер Сентер Высокоаффинные антитела к gd2
JP6668241B2 (ja) 2013-09-05 2020-03-18 アムジエン・インコーポレーテツド 予測可能で、一貫性のある、且つ再現可能な糖型特性を示すFc含有分子
MX377275B (es) 2014-05-16 2025-03-07 Amgen Inc Ensayo para detectar poblaciones celulares linfocitos t colaboradores 1 (th1) y linfocitos t colaboradores (th2).
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
CN107431546B (zh) * 2015-03-24 2020-03-03 第一媒体有限责任公司 高优先级通知系统和方法
DK3294906T3 (en) 2015-05-11 2024-08-05 Natera Inc Methods for determining ploidy
US12146195B2 (en) 2016-04-15 2024-11-19 Natera, Inc. Methods for lung cancer detection
AU2018235928B2 (en) 2017-03-14 2023-09-21 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
CA3067637A1 (en) 2017-06-20 2018-12-27 The Medical College Of Wisconsin, Inc. Assessing transplant complication risk with total cell-free dna
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
CN111954719B (zh) 2018-03-26 2025-07-18 美国安进公司 细胞培养物中产生的抗体的总去岩藻糖基化糖型
JP7573443B2 (ja) 2018-04-14 2024-10-25 ナテラ, インコーポレイテッド 循環腫瘍dnaの個別化された検出を用いる癌検出およびモニタリングの方法
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
CA3152547A1 (en) 2019-09-26 2021-04-01 Amgen Inc. Methods of producing antibody compositions
WO2021236962A1 (en) 2020-05-20 2021-11-25 The Medical College Of Wisconsin, Inc. Compositions and methods for inhibiting cytokine-release syndrome
WO2021247892A1 (en) 2020-06-04 2021-12-09 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
WO2022081824A1 (en) 2020-10-15 2022-04-21 Amgen Inc. Relative unpaired glycans in antibody production methods
EP4352094A1 (de) 2021-06-07 2024-04-17 Amgen Inc. Verwendung von fucosidase zur steuerung des afucosylierungsniveaus glykosylierter proteine
MX2024003852A (es) 2021-10-05 2024-05-24 Amgen Inc Unión al receptor fc-gamma y contenido de glucanos.
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
AU2024256160A1 (en) 2023-04-20 2025-10-02 Amgen Inc. Methods of determining relative unpaired glycan content
WO2025038600A1 (en) 2023-08-14 2025-02-20 Amgen Inc. Methods for reducing yellow color
WO2025101820A1 (en) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
CN119192384A (zh) * 2024-10-25 2024-12-27 杭州华安生物技术有限公司 抗人Acp1蛋白的兔单克隆抗体及其应用和产品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59109269D1 (de) * 1990-06-28 2005-12-15 Hoechst Ag Fusionsproteine mit Immunglobulinanteilen, ihre Herstellung und Verwendung
WO1999019480A2 (en) * 1997-10-15 1999-04-22 Schering Corporation Human receptor proteins; related reagents and methods
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods

Also Published As

Publication number Publication date
US20110027805A1 (en) 2011-02-03
US7838248B2 (en) 2010-11-23
DE69926480T2 (de) 2006-04-13
IL137037A0 (en) 2001-06-14
JP2002500887A (ja) 2002-01-15
AU2337399A (en) 1999-08-09
US20030003542A1 (en) 2003-01-02
US20090004674A1 (en) 2009-01-01
US6664077B1 (en) 2003-12-16
DE69926480D1 (de) 2005-09-08
IL212140A0 (en) 2011-06-30
US7270817B2 (en) 2007-09-18
US6692740B2 (en) 2004-02-17
US20030100062A1 (en) 2003-05-29
CA2318030A1 (en) 1999-07-29
US20040248254A1 (en) 2004-12-09
CA2318030C (en) 2009-02-17
JP4409763B2 (ja) 2010-02-03
US6693171B2 (en) 2004-02-17
ES2245085T3 (es) 2005-12-16
IL137037A (en) 2011-05-31
IL212140A (en) 2013-05-30
US20040138421A1 (en) 2004-07-15
WO1999037773A1 (en) 1999-07-29
EP1049777A1 (de) 2000-11-08
AU750767B2 (en) 2002-07-25
NZ505499A (en) 2002-07-26
EP1049777B1 (de) 2005-08-03
US7993845B2 (en) 2011-08-09

Similar Documents

Publication Publication Date Title
DE69926480D1 (de) Acpl dna und polypeptide
DE69936105D1 (de) Menschliche tslp nukleinsäuren und polypeptide
ATE305510T1 (de) Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
CY1107594T1 (el) DNA ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ IL-1η
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
WO1999041388A3 (en) Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
CY1105405T1 (el) Dna και πολυπεπτιδια il-1ζ, παραλλαγων ματισματος il-1ζ και xrec2
CY1105226T1 (el) Dna και πολυπεπτιδια il-1 εψιλον ανθρωπου
WO2000008180A3 (en) HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
WO2001055211A3 (en) Fil-1 theta dnas and polypeptides
WO1999031256A3 (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
WO2000008177A3 (en) Death associated kinase containing ankyrin repeats (dakar)
WO2000043525A3 (en) Metalloproteinase-disintegrin family members: svph dnas and polypeptides
DE60124380D1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
WO2000008178A3 (en) Murine dna molecules encoding polypeptides having kinase functions
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
EP1690871A3 (de) Xrec2 DNS und Polypeptide
NZ505866A (en) V196 (also known as RAMP2) DNA and polypeptides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1049777

Country of ref document: EP